A Medical Stock On a Mission

In the December 23rd newsletter I referred to my previous articles on Covance relating to how it was a steady stair-stepper stock and has a strong seasonal track record going through the next few months. I suggested it would be a good time to add to an existing position, or take a new position. CVD opened that morning at 87.13

As you can see, over the four weeks since that article, CVD has broken above previous resistance and kept right on going.

Covance is due to announce earnings on Tuesday, February 4th, after the market closes. If you bought CVD on December 23rd, you are now up 10%. If you bought right after the focus on CVD in my November 15th newsletter, you are also up about 10%. If you bought CVD from my initial mention in the May 23rd newsletter, congratulations, you are up 27.4%.

CVD's recent rise seems to have taken a pause on Friday, and it is only 11 trading days until CVD announces earnings. You might be asking yourself if it would make sense to take profits right now.

Did anything change with CVD's fundamentals? No. Is CVD showing any technical setup that could be the prelude to a significant pullback? No. Has any news come out about Covance that should be a red flag? No. In fact, a Jefferies & Co. analyst just upgraded the stock from “Hold” to “Buy”. So the picture that originally got us into the stock has not changed. None of these factors support exiting the stock.

Now CVD has climbed 8.6% in just 9 trading days. The likelihood of big traders taking profits, as well as the potential for an earnings report on February 4th that won't be well-received, suggests this may be a good time to turn a bit conservative on CVD.

First, if you are a stock-only trader, then the proper thing to do is to implement a trailing-stop. I usually recommend 8%, so if CVD retreats 8% off its recent high of 97.48, you should sell the stock. You can always reenter if another good setup in the stock present itself.

Now I will stop here, but in today's newsletter, I cover how to increase the returns of this trade by 30% or more by covering several possible adjustments to this trade.

Of course, there's much more you need to know and many more stocks you can capitalize upon each and every day.  To find out more, including the answer to the above question, type in www.markettamer.com/seasonal-forecaster

By Gregg Harris, MarketTamer Chief Technical Strategist

Copyright (C) 2014 Stock & Options Training LLC

Unless indicated otherwise, at the time of this writing, the author has no positions in any of the above-mentioned securities.

Gregg Harris is the Chief Technical Strategist at MarketTamer.com with extensive experience in the financial sector.

Gregg started out as an Engineer and brings a rigorous thinking to his financial research. Gregg's passion for finance resulted in the creation of a real-time quote system and his work has been featured nationally in publications, such as the Investment Guide magazine.

As an avid researcher, Gregg concentrates on leveraging what institutional and big money players are doing to move the market and create seasonal trend patterns. Using custom research tools, Gregg identifies stocks that are optimal for stock and options traders to exploit these trends and find the tailwinds that can propel stocks to levels that are hidden to the average trader.

Be Sociable, Share!

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.